A recent study showed that blockade of lncRNA PVT1 reduced the expression of PD-L1 through the JAK2/STAT3 pathway, thereby inhibiting cell proliferation and invasion in cisplatin resistant epithelial ovarian cancer [36]. Here, JAK2 is linked to ovarian carcinoma.